Advertisement

Topics

Treeway Company Profile

06:16 EST 19th January 2019 | BioPortfolio


News Articles [2 Associated News Articles listed on BioPortfolio]

Treeway BV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryTreeway BV Treeway is a biotechnology company that develops drugs for the treatment of amyotrophic lateral sclerosis ALS. The company provides pipeline products such as TW001, an oral formulati...

Treeway BV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryTreeway BV Treeway is a biotechnology company that develops drugs for the treatment of amyotrophic lateral sclerosis ALS. The company's pipeline products include TW001, an oral formulation of e...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "Treeway" on BioPortfolio

We have published hundreds of Treeway news stories on BioPortfolio along with dozens of Treeway Clinical Trials and PubMed Articles about Treeway for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Treeway Companies in our database. You can also find out about relevant Treeway Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record